I was just medling with medical archives to learn more about David Stamler.
He was the chief medical officer of Auspex which got bought by Teva for $3.5B. SD-809 was the lead candidate drug for treating chorea. The drug got FDA approval in 2017
This impeccable record could be the reason Stamler is paid a hefty salary. I will not be surprised if ATH434 walks in the footsteps of SD-809
I will wait until the end. I'm not releasing my shares.
- Forums
- ASX - By Stock
- Ann: Alterity Therapeutics Raises $4.8M AUD in Placement
I was just medling with medical archives to learn more about...
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $6.663K | 1.332M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
46 | 38364906 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 20752393 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
46 | 38364906 | 0.005 |
39 | 53023682 | 0.004 |
44 | 45744982 | 0.003 |
15 | 32943014 | 0.002 |
13 | 96870101 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 20752393 | 17 |
0.007 | 20972790 | 19 |
0.008 | 15048071 | 18 |
0.009 | 9032078 | 9 |
0.010 | 2759026 | 5 |
Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
Last
0.5¢ |
  |
Change
0.000 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
0.6¢ | 0.6¢ | 0.5¢ | 1264516 | ||
Last updated 14.17pm 17/05/2024 ? |
Featured News
ATH (ASX) Chart |